Efficacy of Therapy With PRP Injections Versus HA in Patients With Advanced Grade of GONArthrosis
A legfontosabb adatok
- Ki végzi
- Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
- Hol
- Franciaország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 150 fő, tervezett
- Kezdés
- 2025. szept. 18.
- Várható befejezés
- 2028. okt.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- intra-articular injection of HA
- intra-articular injection of PRP
- A regiszteradat frissítve
- 2026. július 7.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with advanced knee osteoarthritis (wear of the knee joint) in one knee. It compares PRP injections with HA (hyaluronic acid) injections into the knee.
- Életkor
- 18 years and older
- Nem
- All sexes
- A betegség stádiuma
- Grade III or IV osteoarthritis in one knee only, confirmed by MRI. Pain of at least 3/10 on a pain scale. BMI under 35.
- Korábbi kezelés
- No anti-inflammatory drugs (NSAIDs) or corticosteroids in the 7 days before joining. No HA knee injection in the past 2 months. No PRP injection in the past 1 year. No corticosteroid injection in the past 5 months. Aspirin up to 160 mg per day for blood thinning is allowed. Corticosteroids on the skin, as drops or inhaled are allowed.
A részvétel fő kizáró okai
- Blood thinners (anticoagulants) that cannot be stopped during the injection period
- Any cancer diagnosed in the last 3 years
- Pregnant women, women in labour or breastfeeding women
- People under legal guardianship or other legal protection
- Not covered by a social security scheme
A regiszter feltételei, szó szerint
Mind a 15 feltétel megnézéseKevesebb
Ki vehet részt
- Age ≥ 18 years
- MRI confirmed grade III or IV unilateral gonarthrosis
- Pain ≥ 3/10 on the visual analogue scale (VAS)
- Patient with a BMI < 35
- Patient capable of giving consent prior to participation in the study
- Affiliated or entitled under a social security scheme
Ki nem vehet részt
- Non-steroidal anti-inflammatory drugs* or corticosteroids** taken in the 7 days prior to inclusion
- Local injection of hyaluronic acid in the 2 months prior to inclusion
- Local injection of PRP within 1 year prior to inclusion
- Local injection of corticosteroids within 5 months prior to inclusion
- Any other reason which, in the opinion of the investigator, could interfere with the evaluation of the study objectives; Acetylsalicylic acid is allowed when it is prescribed as an antiplatelet agent at doses lower than or equal to 160 mg per day. It has, indeed, no anti-inflammatory effect at these doses; Corticosteroids can be administered when they have a local action different from the one applied to the treated knee (cutaneous, instiled or inhaled routes)
- Patient diagnosed with any type of cancer in the last 3 years
- Current anticoagulant treatment that cannot be stopped during the hyaluronic acid or PRP injection protocol period
- Pregnant women, women in labour or breast-feeding women
- Patients under judicial protection (guardianship, curatorship, etc.) or safeguard of justice
Ez a vizsgálat jelenleg itt érhető el: Franciaország.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Gonarthrosis is a chronic pathology affecting the knee joint and tissues. It is characterized by progressive degeneration of articular cartilage, bone and surrounding structures. Diagnosis is based on clinical, biological and radiological criteria.
A teljes eredeti leírásKevesebb
When knee osteoarthritis becomes symptomatic, it leads to pain associated with stiffness and functional discomfort, impacting on patients' quality of life. Patients become sedentary and isolated, which has cardiovascular and psychological consequences, with a proven excess mortality rate.
To date, there are no curative treatments for gonarthrosis. Available treatments are generally aimed at relieving pain, improving joint function and slowing disease progression. Therapeutic approaches most often combine non-pharmacological treatments such as dietary measures, regular physical activity and therapeutic education, with pharmacological treatments: paracetamol, non-steroidal anti-inflammatory drugs, opioids, intra-articular injections of corticosteroids, hyaluronic acid (HA), Platelet Rich Plasma (PRP)... If these are ineffective, particularly in advanced stages (grades III-IV), then surgery for prosthesis is necessary. However, surgery is not an option for all patients, particularly those with co-morbidities, the elderly or those who refuse it.
The osteoarthritis section of the French rheumatology society has drawn up recommendations, with a view to positioning these treatments, standardizing practices and improving the management of gonarthrosis patients in France. These point out that further studies are needed to validate the efficacy of certain treatments, notably intra-articular PRP injections, which are nevertheless widely used in current practice and defended by a consensus of French experts published in 2021. Indeed, the results of several therapeutic trials and meta-analyses already published show that its efficacy is often superior to that of HA, particularly in terms of symptom improvement and over a longer duration. In order to make the case for their use to learned societies, literature data must be enriched, particularly with regard to advanced stages of gonarthrosis, i.e. stages III-IV, which are the most painful. The aim is to propose an effective treatment to relieve the symptoms of patients for whom surgery is not an option.
A vizsgálat 2 csoportja
- HA InjectionsMár használt kezelés, összehasonlításként
Group 1: HA injections (3 injections at 7-day intervals)
Kezelés: intra-articular injection of HA
- PRP InjectionsA vizsgált kezelés
Group 2: PRP injections (3 injections at 15-day intervals)
Kezelés: intra-articular injection of PRP
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Efficacy of Therapy With Intra-articular Injections of PRP Compared With Therapy With Intra-articular Injections of HA, in Patients With Grade III or IV GONArthrosis: a Prospective Randomized Open-label Study
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. július 7.